Lifestyle changes and 14-year change in high-density lipoprotein cholesterol in a cohort of male physicians

Am Heart J. 2011 Apr;161(4):712-8. doi: 10.1016/j.ahj.2010.12.015.

Abstract

Background: Although cross-sectional studies have identified lifestyle factors associated with high-density lipoprotein cholesterol (HDL-C), no studies have examined the association between changes in lifestyle factors and long-term changes in HDL-C.

Methods: We examined the association between changes in lifestyle factors and changes in HDL-C over a 14-year period in a cohort of 4,168 US male physicians, followed up between 1982 and 1997 and with HDL-C measured at both time points. Using linear regression, we examined the association between HDL-C change and categorized changes in alcohol consumption, physical activity, body mass index (BMI), and smoking, adjusting for age, baseline HDL-C, and other covariates.

Results: Stable BMI of <25 kg/m(2) or BMI reduction from ≥25 to <25 kg/m(2) were associated with increases in HDL-C of 3.1 to 4.7 mg/dL over 14 years. Alcohol consumption of ≥1 drink daily or increase in alcohol consumption from <1 to ≥1 drink daily was associated with increases in HDL-C of 2.4 to 3.3 mg/dL over 14 years. Adopting a sedentary lifestyle was associated with decreases in 14-year decreases in HDL-C.

Conclusion: These findings suggest that reductions in BMI and increases in alcohol consumption are associated with 14-year increases in HDL-C, whereas decreases in physical activity are associated with 14-year decreases in HDL-C.

MeSH terms

  • Aged
  • Atorvastatin
  • Cholesterol, HDL / blood
  • Cholesterol, HDL / drug effects*
  • Coronary Disease / blood
  • Coronary Disease / drug therapy
  • Heptanoic Acids / administration & dosage*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
  • Male
  • Middle Aged
  • Pyrroles / administration & dosage*
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Risk Factors
  • Risk Reduction Behavior*
  • Stroke / blood
  • Stroke / drug therapy
  • Time Factors
  • Treatment Outcome

Substances

  • Cholesterol, HDL
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Atorvastatin